Compare Medtronic PLC (MDT) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Mondaycom Ltd — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Mondaycom Ltd trades at $88.96 (market cap $3.76B). The key difference: Medtronic PLC is far larger — about 29.9× Mondaycom Ltd's market cap, and Medtronic PLC pays a 3.28% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Mondaycom Ltd for 16 Days on average.
| MDT | MNDY | |
|---|---|---|
Market Cap | $112.24B | $3.76B |
Volume | 105,663,236 | 836,200 |
Sector | Health | Technology |
52-Week High | $105.35 | $205.24 |
52-Week Low | $73.75 | $58.81 |
Typical Hold Time | 63 Days | 16 Days |
Enterprise Value | $131.58B | $2.92B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
Monday.com (MNDY) trades at $88.91, up 6.47% over the past 24 hours, reflecting strong momentum. The stock exhibits a bullish technical stance with moving averages supporting the uptrend, while fundamentals show robust revenue growth to $1.23 billion in 2025 and consistent earnings beats. Recent news highlights inclusion in growth stock lists and positive coverage around its AI-focused Elevate '26 conference, signaling investor optimism and product innovation.
The outlook for MNDY remains positive given analyst consensus favoring buys and a price target of $108.64, though elevated valuation ratios like a P/E of 37.69 pose risks if growth slows. Key opportunities include enterprise client expansion and AI integration, while risks involve competitive pressures and market volatility. Investors should weigh strong execution against premium pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
